FDA Releases Draft Guidance on Investigational In Vitro Diagnostics Used in Clinical Investigations of Therapeutic Products

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document to help sponsors of clinical trials involving therapeutic products with investigational in vitro diagnostics (IVDs) and institutional review boards (IRBs) comply with the Investigational Device Exemption (IDE) regulation.